GSK: Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of antidengue virus antibody
Chugai Pharmaceutical Co., Ltd. announced that it signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for the development of an anti─dengue virus antibody. Under this agreement, GSK GH will perform
Read full article »
GSK is an England-based multinational biopharmaceutical company that develops and markets medicinal drugs and vaccines for the treatment of a variety of diseases.
Read more